Authors:
Van Laethem, K
Witvrouw, M
Pannecouque, C
Van Remoortel, B
Schmit, JC
Esnouf, R
Kleim, JP
Balzarini, J
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561
Authors:
Pelemans, H
Esnouf, R
Min, KL
Parniak, M
De Clercq, E
Balzarini, J
Citation: H. Pelemans et al., Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a TRP229TYR mutant RT, VIROLOGY, 287(1), 2001, pp. 143-150
Authors:
Degreve, B
Esnouf, R
De Clercq, E
Balzarini, J
Citation: B. Degreve et al., Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase, MOLEC PHARM, 59(2), 2001, pp. 285-293
Authors:
Wang, J
Meersman, F
Esnouf, R
Froeyen, M
Busson, R
Heremans, K
Herdewijn, P
Citation: J. Wang et al., Poly(2-acrylamido-2-methyl-1-propanamide) (PAMPA): A neutral, water-soluble synthetic polymer with double-stranded helix conformation, HELV CHIM A, 84(8), 2001, pp. 2398-2408
Authors:
Degreve, B
Esnouf, R
De Clercq, E
Balzarini, J
Citation: B. Degreve et al., Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of Alanine-167 to tyrosine, MOLEC PHARM, 58(6), 2000, pp. 1326-1332
Authors:
Pelemans, H
Esnouf, R
De Clercq, E
Balzarini, J
Citation: H. Pelemans et al., Mutational analysis of Trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime targetfor the rational design of new non-nucleoside RT inhibitors, MOLEC PHARM, 57(5), 2000, pp. 954-960
Authors:
Esteban-Gamboa, A
Balzarini, J
Esnouf, R
De Clercq, E
Camarasa, MJ
Perez-Perez, MJ
Citation: A. Esteban-gamboa et al., Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase, J MED CHEM, 43(5), 2000, pp. 971-983
Authors:
Andrei, G
Snoeck, R
De Clercq, E
Esnouf, R
Fiten, P
Opdenakker, G
Citation: G. Andrei et al., Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene, J GEN VIROL, 81, 2000, pp. 639-648
Authors:
Froeyen, M
Wroblowski, B
Esnouf, R
De Winter, H
Allart, B
Lescrinier, E
Herdewijn, P
Citation: M. Froeyen et al., Molecular-dynamics studies of single-stranded hexitol, altritol, mannitol,and ribose nucleic acids (HNA, MNA, ANA, and RNA, resp,) and of the stability of HNA center dot RNA, ANA center dot RNA, and MNA center dot RNA duplexes, HELV CHIM A, 83(9), 2000, pp. 2153-2182
Authors:
Balzarini, J
Degreve, B
Esteban-Gamboa, A
Esnouf, R
De Clercq, E
Engelborghs, Y
Camarasa, MJ
Perez-Perez, MJ
Citation: J. Balzarini et al., Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase, FEBS LETTER, 483(2-3), 2000, pp. 181-185
Authors:
Maurinsh, Y
Rosemeyer, H
Esnouf, R
Medvedovici, A
Wang, J
Ceulemans, G
Lescrinier, E
Hendrix, C
Busson, R
Sandra, P
Seela, F
Van Aerschot, A
Herdewijn, P
Citation: Y. Maurinsh et al., Synthesis and pairing properties of oligonucleotides containing 3-hydroxy-4-hydroxymethyl-1-cyclohexanyl nucleosides, CHEM-EUR J, 5(7), 1999, pp. 2139-2150
Authors:
Liekens, S
Leali, D
Neyts, J
Esnouf, R
Rusnati, M
Dell'Era, P
Maudgal, PC
De Clercq, E
Presta, M
Citation: S. Liekens et al., Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds, MOLEC PHARM, 56(1), 1999, pp. 204-213
Authors:
Degreve, B
Esnouf, R
De Clercq, E
Balzarini, J
Citation: B. Degreve et al., Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase, BIOC BIOP R, 264(2), 1999, pp. 338-342